Theragenics has signed an agreement to acquire NeedleTech Products for $47.8 million in cash, subject to adjustment. The acquisition is expected to close in the third quarter of 2008.
Subscribe to our email newsletter
Under the terms of the agreement, Theragenics will pay $47.8 million in cash, plus transaction costs, for NeedleTech, subject to the terms and conditions of the agreement. Theragenics will retain the cash and investments held by NeedleTech, which totaled approximately $5 million as of June 30, 2008.
The purchase price is also subject to a working capital adjustment at closing. Theragenics expects to finance $24.5 million of the purchase price with borrowings on its existing $40 million credit facility and pay the remainder from current cash and investment balances.
Christine Jacobs, chairman and CEO of Theragenics, said: “This acquisition will forward our stated strategy of becoming a diversified medical device manufacturer, will increase our breadth of offerings to our existing customers and will expand our customer base of large leading-edge original equipment manufacturers.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.